At BCCDC, Dr. Janjua provides leadership on surveillance, research and policy advice, and programming related to hepatitis B and C in British Columbia.
- Hepatitis B and C
- Syndemics of substance use, mental illness and blood-borne and sexually transmitted infections (STBBIs)
- Intervention effectiveness
- Health disparities
His research interests include hepatitis B and C epidemiology, syndemics of substance use, mental illness and blood-borne and sexually transmitted infections, intervention effectiveness, disparities in treatment access and disease outcomes, and strategies to enhance access to care.